First Fiduciary Investment Counsel, Inc.
Position in JNJ — Johnson & Johnson
CIK 1072843
CLEVELAND, OH
Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$18,595,937
-$3,653,480 QoQ
Shares Held
73,221
-19.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
3.66%
of 13F equity value
Holder Rank
#774
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First Fiduciary Investment Counsel, Inc. holds $51,339,791 across 7 Drug Manufacturers - General names. JNJ ranks #1 (36.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
73,221 | $18,595,937 | |
| 2 | NVS |
Novartis AG
|
99,224 | $15,550,385 | |
| 3 | AMGN |
Amgen Inc
|
25,171 | $9,114,922 | |
| 4 | PFE |
Pfizer Inc
|
256,357 | $6,173,076 | |
| 5 | MRK |
Merck & Co., Inc.
|
7,118 | $914,663 | |
| 6 | LLY |
ELI LILLY & Co
|
435 | $521,752 | |
| 7 | ABBV |
AbbVie Inc.
|
1,864 | $469,056 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,595,937 | 73,221 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $22,249,417 | 91,022 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $18,352,326 | 88,680 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $17,173,971 | 92,622 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $14,220,566 | 93,097 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $15,273,698 | 92,099 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $13,813,379 | 95,515 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $15,041,436 | 92,814 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $13,612,903 | 93,137 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $14,855,781 | 93,911 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $15,089,046 | 96,268 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $14,536,303 | 93,331 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $15,640,315 | 94,492 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $14,521,020 | 93,684 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $16,891,449 | 95,621 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $16,103,865 | 98,579 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $17,749,934 | 99,994 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $18,195,140 | 102,664 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $17,815,229 | 104,140 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $16,702,168 | 103,419 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $17,585,995 | 106,750 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $17,989,257 | 109,457 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $19,462,555 | 123,666 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $18,516,503 | 124,372 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $17,411,681 | 123,812 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $16,143,938 | 123,114 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||